1. Home
  2. XBIO vs HAO Comparison

XBIO vs HAO Comparison

Compare XBIO & HAO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XBIO
  • HAO
  • Stock Information
  • Founded
  • XBIO N/A
  • HAO 2018
  • Country
  • XBIO United States
  • HAO China
  • Employees
  • XBIO N/A
  • HAO N/A
  • Industry
  • XBIO Biotechnology: Pharmaceutical Preparations
  • HAO
  • Sector
  • XBIO Health Care
  • HAO
  • Exchange
  • XBIO Nasdaq
  • HAO NYSE
  • Market Cap
  • XBIO 6.3M
  • HAO 7.4M
  • IPO Year
  • XBIO N/A
  • HAO 2024
  • Fundamental
  • Price
  • XBIO $4.06
  • HAO $0.12
  • Analyst Decision
  • XBIO Hold
  • HAO
  • Analyst Count
  • XBIO 1
  • HAO 0
  • Target Price
  • XBIO N/A
  • HAO N/A
  • AVG Volume (30 Days)
  • XBIO 22.9K
  • HAO 7.4M
  • Earning Date
  • XBIO 11-12-2024
  • HAO 10-29-2024
  • Dividend Yield
  • XBIO N/A
  • HAO N/A
  • EPS Growth
  • XBIO N/A
  • HAO 20.20
  • EPS
  • XBIO N/A
  • HAO 0.04
  • Revenue
  • XBIO $2,523,427.00
  • HAO $48,519,836.00
  • Revenue This Year
  • XBIO N/A
  • HAO N/A
  • Revenue Next Year
  • XBIO N/A
  • HAO N/A
  • P/E Ratio
  • XBIO N/A
  • HAO $3.23
  • Revenue Growth
  • XBIO 7.15
  • HAO 71.88
  • 52 Week Low
  • XBIO $2.78
  • HAO $0.12
  • 52 Week High
  • XBIO $5.20
  • HAO $10.60
  • Technical
  • Relative Strength Index (RSI)
  • XBIO 47.20
  • HAO 36.85
  • Support Level
  • XBIO $3.92
  • HAO $0.12
  • Resistance Level
  • XBIO $4.27
  • HAO $0.14
  • Average True Range (ATR)
  • XBIO 0.27
  • HAO 0.02
  • MACD
  • XBIO -0.05
  • HAO 0.01
  • Stochastic Oscillator
  • XBIO 19.09
  • HAO 40.79

About XBIO Xenetic Biosciences Inc.

Xenetic Biosciences Inc is a biopharmaceutical company focused on advancing immune-oncology technologies addressing cancers. The company is also engaged in progressing XCART, a personalized CAR T platform technology. The Company's DNase platform is designed to improve outcomes of existing treatments, including immunotherapies, by targeting neutrophil extracellular traps (NETs), which have been implicated in cancer progression and resistance to cancer treatments. The company also has oncology therapeutic investigational drug candidate XBIO-101 for the treatment of progestin-resistant endometrial cancer.

About HAO HAOXI HEALTH TECHNOLOGY LTD

Haoxi Health Technology Ltd is an online marketing solution provider in China, with an advertiser client base mainly in the healthcare industry. Haoxi has been rooted in the field of local online effect marketing for many years, serving leading customers in various industries at home and abroad, and its main business is the medical industry. It generates its revenue by providing one-stop online marketing solutions, in particular online short video marketing solutions, to advertisers through its media partners. The company provides customized marketing solutions by planning, producing, placing, and optimizing online ads, especially online short video ads, to help its advertisers acquire, convert, and retain ultimate consumers on various online media platforms.

Share on Social Networks: